RS49733B - Soli bpc peptida sa organo- zaštitnom aktivnošću, postupak za njihovo dobijanje i njihova primena - Google Patents

Soli bpc peptida sa organo- zaštitnom aktivnošću, postupak za njihovo dobijanje i njihova primena

Info

Publication number
RS49733B
RS49733B YUP-601/99A YU60199A RS49733B RS 49733 B RS49733 B RS 49733B YU 60199 A YU60199 A YU 60199A RS 49733 B RS49733 B RS 49733B
Authority
RS
Serbia
Prior art keywords
amino acid
acid residue
salt
prgano
preparation
Prior art date
Application number
YUP-601/99A
Other languages
English (en)
Inventor
Predrag dr.sc. Sikirić
Marijan Mr.Sc. Petek
Sven Seiwerth
Branko Turković
Željko Grabarević
Ivo Rotkvić
Stjepan mr.sc. Mise
Marko Duvnjak
Ivan Udovičić
Original Assignee
Sikirić, Predrag dr.sc..,
Marijan Mr.Sc. Petek
Sven Seiwerth
Branko Turković
Željko Grabarević
Ivo Rotkvić
Stjepan mr.sc. Mise
Marko Duvnjak
Ivan Udovičić
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sikirić, Predrag dr.sc..,, Marijan Mr.Sc. Petek, Sven Seiwerth, Branko Turković, Željko Grabarević, Ivo Rotkvić, Stjepan mr.sc. Mise, Marko Duvnjak, Ivan Udovičić filed Critical Sikirić, Predrag dr.sc..,
Publication of YU60199A publication Critical patent/YU60199A/sh
Publication of RS49733B publication Critical patent/RS49733B/sr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Reproductive Health (AREA)
  • Cardiology (AREA)
  • Zoology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Psychology (AREA)
  • Hematology (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

So BPC (jedinjenje za zaštitu tela) peptida koja se sastoji od 8-15 aminokiselinskih ostataka naznačena time, što je anjon soli negativno šaržiran peptid koji obuhvata 8 aminokiselinskih ostataka i koji ima opštu formulu (Zaa Pro Pro Pro Xaa Yaa Pro Ala)(-) ili (2-) gde Xaa je neutralni alifatični ostatak amino kiseline, Yaa je ostatak bazne amino kiseline i Zaa je kiseli ostatak amino kiseline, I gde katjon soli je katjon neorganske ili organske ne-toksične baze. Prijava sadrži još 5 nezavisnih i 9 zavisnih patentnih zahteva.
YUP-601/99A 1997-05-23 1998-05-20 Soli bpc peptida sa organo- zaštitnom aktivnošću, postupak za njihovo dobijanje i njihova primena RS49733B (sr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP97108384 1997-05-23

Publications (2)

Publication Number Publication Date
YU60199A YU60199A (sh) 2002-09-19
RS49733B true RS49733B (sr) 2008-04-04

Family

ID=8226822

Family Applications (1)

Application Number Title Priority Date Filing Date
YUP-601/99A RS49733B (sr) 1997-05-23 1998-05-20 Soli bpc peptida sa organo- zaštitnom aktivnošću, postupak za njihovo dobijanje i njihova primena

Country Status (28)

Country Link
US (1) US6288028B1 (sr)
EP (1) EP0983300B1 (sr)
JP (1) JP3492381B2 (sr)
KR (1) KR100488038B1 (sr)
CN (1) CN1166683C (sr)
AR (1) AR011478A1 (sr)
AT (1) ATE277948T1 (sr)
AU (1) AU731317B2 (sr)
BG (1) BG64023B1 (sr)
BR (1) BR9809457B1 (sr)
CA (1) CA2290739C (sr)
CZ (1) CZ299423B6 (sr)
DE (1) DE69826653T2 (sr)
DK (1) DK0983300T3 (sr)
EA (1) EA002058B1 (sr)
ES (1) ES2229507T3 (sr)
HU (1) HU227800B1 (sr)
ID (1) ID23184A (sr)
IL (2) IL132884A0 (sr)
NO (1) NO321126B1 (sr)
NZ (1) NZ501323A (sr)
PL (1) PL193790B1 (sr)
PT (1) PT983300E (sr)
RS (1) RS49733B (sr)
SK (1) SK159599A3 (sr)
TR (1) TR199902866T2 (sr)
UA (1) UA61955C2 (sr)
WO (1) WO1998052973A1 (sr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1731160B1 (en) * 2004-02-27 2012-07-11 Fuji Oil Company, Ltd. Cancer metastasis inhibitory composition
US8022216B2 (en) * 2007-10-17 2011-09-20 Wyeth Llc Maleate salts of (E)-N-{4-[3-chloro-4-(2-pyridinylmethoxy)anilino]-3-cyano-7-ethoxy-6-quinolinyl}-4-(dimethylamino)-2-butenamide and crystalline forms thereof
SI24318A (sl) * 2013-03-13 2014-09-30 Diagen D.O.O. Nove stabilne soli pentadekapeptida, postopek za njihovo pripravo, njihova uporaba za izdelavo farmacevtskih pripravkov in njihova uporaba v terapiji
US10350293B2 (en) 2016-08-23 2019-07-16 Pharmacotherapia d.o.o. Compositions and methods for treating symptoms associated with multiple sclerosis
WO2019038412A1 (en) 2017-08-24 2019-02-28 Novo Nordisk A/S GLP-1 COMPOSITIONS AND USES THEREOF
BR112022013746A2 (pt) 2020-02-18 2022-10-11 Novo Nordisk As Formulação aquosa de cagrilintida, formulação aquosa de semaglutida, dispositivo médico, e, combinação de dose fixa
US11065298B1 (en) * 2020-04-24 2021-07-20 Chanda Zaveri Compositions and methods for treating or preventing viral infections
US11833189B1 (en) * 2023-05-15 2023-12-05 Red Mountain Med Spa, LLC Sublingual Semaglutide-BPC 157 combination for weight loss

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6901191A (en) * 1990-09-11 1992-03-30 Marko Duvnjak Pharmacologically active substance bpc, the process for its preparation and its use in the therapy
DK0572688T3 (da) 1992-05-30 1997-12-01 Sikiric Predrag Peptider, med organ-beskyttende aktivitet, fremgangsmåde til deres fremstilling og deres anvendelse ved terapi
PL304666A1 (en) * 1992-11-16 1995-01-09 Predrag Sikiric Peptides of organoprotective activity, method of obtaining them and their application in therapy

Also Published As

Publication number Publication date
CN1166683C (zh) 2004-09-15
DK0983300T3 (da) 2005-01-31
PL336897A1 (en) 2000-07-17
AU731317B2 (en) 2001-03-29
ID23184A (id) 2000-03-23
HUP0002329A1 (hu) 2000-12-28
PT983300E (pt) 2005-02-28
CA2290739A1 (en) 1998-11-26
UA61955C2 (en) 2003-12-15
BR9809457A (pt) 2000-06-20
WO1998052973A1 (en) 1998-11-26
US6288028B1 (en) 2001-09-11
KR20010012895A (ko) 2001-02-26
CZ9904142A3 (cs) 2002-03-13
HU227800B1 (en) 2012-03-28
NO995692D0 (no) 1999-11-19
BR9809457B1 (pt) 2010-11-30
JP3492381B2 (ja) 2004-02-03
DE69826653D1 (de) 2004-11-04
DE69826653T2 (de) 2006-03-09
NZ501323A (en) 2001-04-27
HUP0002329A3 (en) 2001-03-28
ATE277948T1 (de) 2004-10-15
BG64023B1 (bg) 2003-10-31
AR011478A1 (es) 2000-08-16
EP0983300A1 (en) 2000-03-08
CN1257510A (zh) 2000-06-21
ES2229507T3 (es) 2005-04-16
KR100488038B1 (ko) 2005-05-09
BG103905A (en) 2000-07-31
AU7914198A (en) 1998-12-11
YU60199A (sh) 2002-09-19
SK159599A3 (en) 2000-11-07
IL132884A0 (en) 2001-03-19
NO321126B1 (no) 2006-03-20
JP2000515558A (ja) 2000-11-21
IL132884A (en) 2007-08-19
PL193790B1 (pl) 2007-03-30
NO995692L (no) 2000-01-24
EA002058B1 (ru) 2001-12-24
CZ299423B6 (cs) 2008-07-23
EA199901061A1 (ru) 2000-06-26
TR199902866T2 (xx) 2000-02-21
CA2290739C (en) 2007-06-26
EP0983300B1 (en) 2004-09-29

Similar Documents

Publication Publication Date Title
FI801035A (fi) Foerfarande foer enzymatisk framstaellning av peptider
RS49733B (sr) Soli bpc peptida sa organo- zaštitnom aktivnošću, postupak za njihovo dobijanje i njihova primena
ES8702437A1 (es) Procedimiento para la obtencion de tetrapeptidos sustituidos
NO834340L (no) Nye polypeptider
PT888271E (pt) Derivados de benzamidina substituidos com derivados de aminoacidos e hidroxiacidos e sua utilizacao como anticoagulantes
ATE355297T1 (de) Tgf-beta inhibitoren und methoden
ES2012720A6 (es) Procedimiento para la obtencion de sales de adicion de acido de taurina o glicina amidada.
BR0310003A (pt) compostos peptìdeos e seu uso como substratos de protease
LV10108A (lv) Sunu proliferacijas inhibitori farmaceitiska kompozicija savienojumu iegusanas metode sunu proliferacijas inhibesanas panemieni
ES2003112A6 (es) Un procedimiento para la preparacion de un decapeptido.
GB1292820A (en) Haematinic preparations
EP0222283A3 (en) Amino-acid derivatives
ATE60788T1 (de) Derivat von p-aminophenol mit mucrosekretolytischer fluessiger und antipyretischer wirksamkeit, dessen verfahren zur herstellung und dessen pharmazeutische zusammensetzungen.
ATE223927T1 (de) Mu-opioidligande: agonisten und antagonisten
TR200001760T1 (tr) Sınıf III antiarritmik bileşim içeren ispençiyari müstahzar
NO884226L (no) Korrosjonsbeskyttelsesmiddel.
JPS6415385A (en) Use of sulfonamide carboxylate as corrosion inhibitor of aqueous system
ATE125566T1 (de) Superoxid-dismutaseanaloge mit neuen bindeeigenschaften.
EA199800289A1 (ru) Производные пептидов
ES2077021T3 (es) Peptidos que tienen actividad inhibidora de renina, su preparacion y uso.
IS3782A7 (is) Aðferð við framleiðslu nýrra heteróhringtengdra efnasambanda, sem eru mótlyf örvandi amínósýrunema
GB1533129A (en) Process for producing a peptide in the presence of an enzyme
PT1363656E (pt) Tripeptideos e derivados de tripeptideos para o tratamento de doencas pos-lesionais do sistema nervoso
ATE92078T1 (de) Pharmakologisch aktive peptide.
ATE46173T1 (de) Pharmakologisch aktive peptide.